WO2024060636A1 - 含酯类成核剂的聚羟基烷酸酯组合物、聚羟基烷酸酯成型体及其制备方法 - Google Patents
含酯类成核剂的聚羟基烷酸酯组合物、聚羟基烷酸酯成型体及其制备方法 Download PDFInfo
- Publication number
- WO2024060636A1 WO2024060636A1 PCT/CN2023/092674 CN2023092674W WO2024060636A1 WO 2024060636 A1 WO2024060636 A1 WO 2024060636A1 CN 2023092674 W CN2023092674 W CN 2023092674W WO 2024060636 A1 WO2024060636 A1 WO 2024060636A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polyhydroxyalkanoate
- temperature
- hydroxybutyrate
- poly
- nucleating agent
- Prior art date
Links
- 229920000903 polyhydroxyalkanoate Polymers 0.000 title claims abstract description 108
- 239000005014 poly(hydroxyalkanoate) Substances 0.000 title claims abstract description 105
- 239000002667 nucleating agent Substances 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 150000002148 esters Chemical class 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 238000002425 crystallisation Methods 0.000 claims abstract description 42
- 230000008025 crystallization Effects 0.000 claims abstract description 42
- -1 ester compound Chemical class 0.000 claims abstract description 37
- 238000000034 method Methods 0.000 claims abstract description 25
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 5
- 238000000465 moulding Methods 0.000 claims description 39
- 238000002844 melting Methods 0.000 claims description 21
- 230000008018 melting Effects 0.000 claims description 21
- 230000009477 glass transition Effects 0.000 claims description 11
- 238000010438 heat treatment Methods 0.000 claims description 11
- FLIACVVOZYBSBS-UHFFFAOYSA-N Methyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC FLIACVVOZYBSBS-UHFFFAOYSA-N 0.000 claims description 10
- XIRNKXNNONJFQO-UHFFFAOYSA-N ethyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC XIRNKXNNONJFQO-UHFFFAOYSA-N 0.000 claims description 10
- QSQLTHHMFHEFIY-UHFFFAOYSA-N methyl behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OC QSQLTHHMFHEFIY-UHFFFAOYSA-N 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 9
- HPEUJPJOZXNMSJ-UHFFFAOYSA-N Methyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC HPEUJPJOZXNMSJ-UHFFFAOYSA-N 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- PTEYJUIKYIKULL-UHFFFAOYSA-N Ethyl pentadecanoate Chemical compound CCCCCCCCCCCCCCC(=O)OCC PTEYJUIKYIKULL-UHFFFAOYSA-N 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 229920000520 poly(3-hydroxybutyrate-co-3-hydroxyvalerate) Polymers 0.000 claims description 5
- 229920001013 poly(3-hydroxybutyrate-co-4-hydroxybutyrate) Polymers 0.000 claims description 5
- 229920000070 poly-3-hydroxybutyrate Polymers 0.000 claims description 5
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 claims description 4
- NDKYEUQMPZIGFN-UHFFFAOYSA-N Butyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCC NDKYEUQMPZIGFN-UHFFFAOYSA-N 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- QGBRLVONZXHAKJ-UHFFFAOYSA-N methyl arachidate Chemical compound CCCCCCCCCCCCCCCCCCCC(=O)OC QGBRLVONZXHAKJ-UHFFFAOYSA-N 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- MMXKVMNBHPAILY-UHFFFAOYSA-N ethyl laurate Chemical compound CCCCCCCCCCCC(=O)OCC MMXKVMNBHPAILY-UHFFFAOYSA-N 0.000 claims 2
- YBKSMWBLSBAFBQ-UHFFFAOYSA-N eicosanoic acid ethyl ester Natural products CCCCCCCCCCCCCCCCCCCC(=O)OCC YBKSMWBLSBAFBQ-UHFFFAOYSA-N 0.000 claims 1
- 238000012545 processing Methods 0.000 abstract description 38
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 16
- 229930195729 fatty acid Natural products 0.000 abstract description 16
- 239000000194 fatty acid Substances 0.000 abstract description 16
- 230000008569 process Effects 0.000 abstract description 13
- 229920001169 thermoplastic Polymers 0.000 abstract description 7
- 239000004416 thermosoftening plastic Substances 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 5
- 125000004432 carbon atom Chemical group C* 0.000 abstract description 4
- 230000006911 nucleation Effects 0.000 abstract description 3
- 238000010899 nucleation Methods 0.000 abstract description 3
- 230000007547 defect Effects 0.000 abstract 1
- 239000010408 film Substances 0.000 description 26
- 239000002245 particle Substances 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 14
- JIZCYLOUIAIZHQ-UHFFFAOYSA-N ethyl docosenyl Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC JIZCYLOUIAIZHQ-UHFFFAOYSA-N 0.000 description 12
- 238000002834 transmittance Methods 0.000 description 11
- 238000004519 manufacturing process Methods 0.000 description 10
- 238000005469 granulation Methods 0.000 description 9
- 230000003179 granulation Effects 0.000 description 9
- 238000001125 extrusion Methods 0.000 description 8
- WHBMMWSBFZVSSR-UHFFFAOYSA-M 3-hydroxybutyrate Chemical compound CC(O)CC([O-])=O WHBMMWSBFZVSSR-UHFFFAOYSA-M 0.000 description 7
- WHBMMWSBFZVSSR-UHFFFAOYSA-N R3HBA Natural products CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- 238000005520 cutting process Methods 0.000 description 6
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 208000037534 Progressive hemifacial atrophy Diseases 0.000 description 5
- 230000000813 microbial effect Effects 0.000 description 5
- 238000012017 passive hemagglutination assay Methods 0.000 description 5
- 229920001020 poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) Polymers 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 238000001938 differential scanning calorimetry curve Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229940074979 cetyl palmitate Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 229920000739 poly(3-hydroxycarboxylic acid) polymer Polymers 0.000 description 3
- HPMGFDVTYHWBAG-UHFFFAOYSA-N 3-hydroxyhexanoic acid Chemical compound CCCC(O)CC(O)=O HPMGFDVTYHWBAG-UHFFFAOYSA-N 0.000 description 2
- REKYPYSUBKSCAT-UHFFFAOYSA-N 3-hydroxypentanoic acid Chemical compound CCC(O)CC(O)=O REKYPYSUBKSCAT-UHFFFAOYSA-N 0.000 description 2
- SJZRECIVHVDYJC-UHFFFAOYSA-M 4-hydroxybutyrate Chemical compound OCCCC([O-])=O SJZRECIVHVDYJC-UHFFFAOYSA-M 0.000 description 2
- FARPMBPKLYEDIL-UHFFFAOYSA-N S-3-Hydroxyundecanoic acid Natural products CCCCCCCCC(O)CC(O)=O FARPMBPKLYEDIL-UHFFFAOYSA-N 0.000 description 2
- BIRUBGLRQLAEFF-UHFFFAOYSA-N Triacontanoic acid methyl ester Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)OC BIRUBGLRQLAEFF-UHFFFAOYSA-N 0.000 description 2
- 229920006167 biodegradable resin Polymers 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- AKXFYSSXNQQBNT-UHFFFAOYSA-N ethyl tetracosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCC AKXFYSSXNQQBNT-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- BDXAHSJUDUZLDU-UHFFFAOYSA-N methyl nonadecanoate Chemical compound CCCCCCCCCCCCCCCCCCC(=O)OC BDXAHSJUDUZLDU-UHFFFAOYSA-N 0.000 description 2
- XUDJZDNUVZHSKZ-UHFFFAOYSA-N methyl tetracosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCCCC(=O)OC XUDJZDNUVZHSKZ-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 238000005453 pelletization Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000010902 straw Substances 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- FYSSBMZUBSBFJL-VIFPVBQESA-N (S)-3-hydroxydecanoic acid Chemical compound CCCCCCC[C@H](O)CC(O)=O FYSSBMZUBSBFJL-VIFPVBQESA-N 0.000 description 1
- BTJFTHOOADNOOS-UHFFFAOYSA-N 2-hydroxynonanoic acid Chemical compound CCCCCCCC(O)C(O)=O BTJFTHOOADNOOS-UHFFFAOYSA-N 0.000 description 1
- OXSSIXNFGTZQMZ-UHFFFAOYSA-N 3-hydroxyheptanoic acid Chemical compound CCCCC(O)CC(O)=O OXSSIXNFGTZQMZ-UHFFFAOYSA-N 0.000 description 1
- NDPLAKGOSZHTPH-UHFFFAOYSA-N 3-hydroxyoctanoic acid Chemical compound CCCCCC(O)CC(O)=O NDPLAKGOSZHTPH-UHFFFAOYSA-N 0.000 description 1
- ALRHLSYJTWAHJZ-UHFFFAOYSA-M 3-hydroxypropionate Chemical compound OCCC([O-])=O ALRHLSYJTWAHJZ-UHFFFAOYSA-M 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004970 Chain extender Substances 0.000 description 1
- ORAWFNKFUWGRJG-UHFFFAOYSA-N Docosanamide Chemical compound CCCCCCCCCCCCCCCCCCCCCC(N)=O ORAWFNKFUWGRJG-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- OFIDNKMQBYGNIW-UHFFFAOYSA-N arachidonic acid methyl ester Natural products CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC OFIDNKMQBYGNIW-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229920013724 bio-based polymer Polymers 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 238000003490 calendering Methods 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- CAMHHLOGFDZBBG-UHFFFAOYSA-N epoxidized methyl oleate Natural products CCCCCCCCC1OC1CCCCCCCC(=O)OC CAMHHLOGFDZBBG-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 229940067592 ethyl palmitate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 125000005313 fatty acid group Chemical group 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000010128 melt processing Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K5/00—Use of organic ingredients
- C08K5/04—Oxygen-containing compounds
- C08K5/10—Esters; Ether-esters
- C08K5/101—Esters; Ether-esters of monocarboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2201/00—Properties
- C08L2201/10—Transparent films; Clear coatings; Transparent materials
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2205/00—Polymer mixtures characterised by other features
- C08L2205/24—Crystallisation aids
Definitions
- the present invention relates to the technical field of polyhydroxyalkanoate materials, and in particular to a polyhydroxyalkanoate composition containing an ester nucleating agent, a polyhydroxyalkanoate molded body and a preparation method thereof.
- Polyhydroxyalkanoates are intracellular polyhydroxyalkanoates synthesized by many microorganisms and are natural polymer biomaterials. Most monomers of polyhydroxyalkanoates are 3-hydroxy fatty acids with a chain length of 3 to 14 carbon atoms, and their side chains are highly variable saturated or unsaturated, linear or branched, aliphatic or aromatic groups. The diversity of the composition structure brings about the diversity of performance, which gives it obvious advantages in application.
- polyhydroxyalkanoates are a bio-based polymer that is biodegradable in the marine environment. They can solve the environmental problems caused by waste plastics and have excellent biocompatibility and mechanical properties. Therefore, they can be processed into various molded bodies, such as films, straws, tableware, etc.
- Simple polyhydroxyalkanoates have shortcomings such as slow crystallization rate, low crystallinity, and low processing efficiency during thermoplastic processing to prepare various molded bodies.
- the existing technology often increases the crystallization rate of PHAs by adding nucleating agents and other additives.
- nucleating agents are usually mainly inorganic substances or metal salts. Although they can improve the crystallization speed and crystallinity of molded bodies prepared by traditional polyhydroxyalkanoates to a certain extent, the degree of improvement is limited; more importantly, It will cause the molded body to be colored, reduce its transparency and affect its application.
- One of the objects of the present invention is to provide a polyhydroxyalkanoate composition containing an ester nucleating agent.
- the second object of the present invention is to provide a polyhydroxyalkanoate molded body prepared from the above-mentioned polyhydroxyalkanoate composition.
- the third object of the present invention is to provide a method for preparing the above-mentioned polyhydroxyalkanoate molded body.
- the present invention provides a polyhydroxyalkanoate composition, comprising:
- a nucleating agent wherein the nucleating agent includes at least one ester compound.
- the polyhydroxyalkanoate may be a single polymer or a combination of two or more polymers.
- the polymerized monomers of each polymer may be one or more types (ie, the structural units in the polymer may be one or more types).
- any polymer contains structural units represented by the following general formula (1):
- R 1 is an alkyl group represented by C p H 2p+1 , and p is an integer of 1 to 15, preferably an integer of 1 to 10, more preferably an integer of 1 to 8;
- examples of R 1 include: Methyl, ethyl, propyl, n-butyl, isobutyl, tert-butyl, pentyl, hexyl and other linear or branched alkyl groups;
- n 1, 2 or 3.
- the 3-hydroxyalkanoate structural unit and the 4-hydroxyalkanoate structural unit are more common, such as the 3-hydroxybutyrate structural unit (hereinafter sometimes referred to as 3HB) and the 4-hydroxybutyrate structural unit (hereinafter sometimes referred to as 4HB).
- the polyhydroxyalkanoate includes at least one poly(3-hydroxyalkanoate).
- the poly(3-hydroxyalkanoate) is a poly(3-hydroxybutyrate) homopolymer containing only 3-hydroxybutyrate structural units, or a poly(3-hydroxybutyrate) copolymer containing 3-hydroxybutyrate structural units and other hydroxyalkanoate structural units.
- the other hydroxyalkanoate structural units include: 3-hydroxypropionate, 3-hydroxyvalerate, 3-hydroxycaproate, 3-hydroxyheptanoate, 3-hydroxyoctanoate, 3 -One or more of hydroxynonanoate, 3-hydroxydecanoate, 3-hydroxyundecanoate or 4-hydroxybutyrate; preferably 3-hydroxycaproate.
- poly(3-hydroxyalkanoate) examples include poly(3-hydroxybutyrate) and poly(3-hydroxybutyrate-co-3-hydroxypropionate).
- poly(3-hydroxybutyrate-co-3-hydroxyvalerate) abbreviation: P3HB3HV, hereinafter referred to as PHBV
- poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3 -hydroxycaproate) hereinafter referred to as P3HB3HV3HH
- poly(3-hydroxybutyrate-co-3-hydroxycaproate) referred to as: P3HB3HH, hereinafter referred to as PHBH
- poly(3-hydroxybutyrate-co- -3-hydroxyheptanoate) poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) (hereinafter referred to as PHBO)
- poly(3-hydroxybutyrate-co-3-hydroxynonanoate) poly(3-hydroxybutyrate-co-3-co-3-
- the production method of the polyhydroxyalkanoate is not particularly limited, and may be a production method using chemical synthesis or a production method using microorganisms.
- the polyhydroxyalkanoate of the present invention is particularly preferably a polyhydroxyalkanoate produced by microorganisms.
- all 3-hydroxyalkanoate structural units are (R) 3-hydroxyalkanoates. Contains in the form of acid ester structural units.
- the average content ratio of the 3-hydroxybutyrate structural units to other hydroxyalkanoate structural units is 50/50 ⁇ 99/1 (mol%/mol%); preferably 80/20 ⁇ 94/6 (mol%/mol%); when the polyhydroxyalkanoate raw material is a mixture of two or more polyhydroxyalkanoates
- the average content ratio refers to the molar ratio of each monomer contained in the entire mixture.
- the weight average molecular weight of the polyhydroxyalkanoate is 100,000 to 1,000,000; preferably 200,000 to 900,000; further preferably 300,000 to 800,000.
- the weight average molecular weight is less than 100,000, the mechanical properties of the obtained polyhydroxyalkanoate molded article tend to be reduced.
- the weight average molecular weight exceeds 1 million, the load on machinery during melt processing tends to increase and productivity tends to decrease.
- the nucleating agent of the present invention includes at least one ester compound.
- the ester compound is a fatty acid ester compound, that is, in R-COO-R', R is a C5-C30 alkyl group (that is, R-COOH used to synthesize R-COO-R' is a fatty acid), and R' is a C1-C16 alkyl group.
- the nucleating agent is at least one fatty acid ester with a carbon number greater than 5; preferably, the nucleating agent is at least one fatty acid ester with a carbon number greater than 12; more preferably, the nucleating agent is The nucleating agent is at least one fatty acid ester with a carbon number greater than 18.
- the upper limit of the number of carbon atoms is not particularly limited, but may be, for example, 45 or less, 40 or less, or 35 or less.
- ester compounds as nucleating agents, including fatty acid ester compounds, such as fatty acid esters with more than 5 carbon atoms, are used as nucleating agents in the preparation of polyhydroxyalkanoate molded bodies, which can significantly improve the performance of polyhydroxyalkanoates.
- the crystallization speed and crystallinity of the acid ester when preparing the molded body have the advantages of high nucleation efficiency and simpler processing.
- the prepared polyhydroxyalkanoate molded body has the advantage of high transparency, so it has more A wide range of application scenarios.
- the nucleating agent is preferably a saturated fatty acid ester.
- the nucleating agent is selected from the group consisting of butyl dodecanoate (also known as butyl dodecanoate and butyl laurate), ethyl pentadecanoate (also known as ethyl pentadecanoate), and hexadecanoic acid ethyl.
- butyl dodecanoate also known as butyl dodecanoate and butyl laurate
- ethyl pentadecanoate also known as ethyl pentadecanoate
- hexadecanoic acid ethyl hexadecanoic acid
- Methyl hexadecanoate also known as methyl hexadecanoate, methyl palmitate
- ethyl hexadecanoate Also known as ethyl hexadecanoate, ethyl palmitate
- 2-ethylhexyl hexadecanoate also known as 2-ethylhexyl palmitate, octyl palmitate
- cetyl palmitate or Called cetyl palmitate, palmityl palmitate, cetyl palmitate
- methyl octadecanoate or methyl stearate
- Methyl arachidate Methyl behenate (or ethyl behenate), methyl behenate (or methyl behenate), ethyl behenate (or ethyl behenate)
- methyl behenate or methyl behenate
- ethyl behenate or ethyl behenate
- the nucleating agent is selected from the group consisting of ethyl hexadecanoate, 2-ethylhexyl hexadecanoate, cetyl hexadecanoate, methyl nonadecanate, methyl eicosate, and eicosate. At least one of ethyl ester, methyl behenate, ethyl behenate, methyl behenate, ethyl behenate, and methyl triaconate.
- the added amount of the nucleating agent is 0.01%-20% of the mass of the polyhydroxyalkanoate; preferably 0.1%-5%; typically without limitation, it can be 0.1%, 1%, 2%, 2.5%, 3%, 4%, 5%.
- the polyhydroxyalkanoate composition of the present invention can be prepared using conventional techniques and conventional equipment known in the art, and can be directly mixed in a mixing equipment to obtain a powder, for example, using a high-speed mixer to blend at room temperature.
- the polyhydroxyalkanoate composition of the present invention may also contain additives and other auxiliaries according to the production needs of the product.
- the additives may include plasticizers, cross-linking agents, chain extenders, lubricants and other organic or inorganic materials.
- Organic or inorganic materials may be used alone or in combination of two or more.
- the addition amount of the additive can also be adjusted according to production needs, and the present invention has no particular limitation on this.
- the present invention also provides a polyhydroxyalkanoate molded body prepared from the polyhydroxyalkanoate composition according to the present invention.
- the polyhydroxyalkanoate molded body obtained by the present invention has the advantages of high transparency and good mechanical properties, and therefore has a wider range of application scenarios.
- the polyhydroxyalkanoate molded body of the present invention can include various forms, such as films, fibers, straws, plates, pellets, paper plastics, sheets, etc.
- the present invention also provides a method for preparing the polyhydroxyalkanoate molded body, which includes: molding with the polyhydroxyalkanoate composition according to the present invention.
- the polyhydroxyalkanoate molded body of the present invention can be prepared by various thermal processing molding methods such as extrusion molding, injection molding, calendering molding, tape molding, blow molding, biaxial stretching molding, etc., or can also be prepared by solution pouring It is prepared by other non-thermal processing molding methods. Preferably it is produced by hot working forming methods.
- the thermal processing molding preparation method of the polyhydroxyalkanoate molded body provided by the invention includes the following steps: The clear polyhydroxyalkanoate composition is heated and melted at a temperature higher than the melting temperature of the polyhydroxyalkanoate; extended at a temperature between the glass transition temperature and the cold crystallization temperature of the polyhydroxyalkanoate; The polyhydroxyalkanoate is cooled and molded at a temperature between its glass transition temperature and melting temperature.
- the molded body when it is pellets, it can be made with granulation equipment: parallel co-rotating twin-screw extruders, parallel counter-rotating twin-screw extruders, and conical twin-screw extruders with different aspect ratios can be used.
- extrusion granulation equipment commonly used in this field such as single-screw extruders; place the composition in the lower hopper of the twin-screw extruder or a weight loss scale; set the temperature of the extrusion granulation equipment within the range of 50°C to 180°C.
- the main engine speed is 50-500r/min, and the feeding amount or production capacity can be adjusted according to the actual production status; subsequent cutting can be performed such as air-cooled strand cutting, water bath strand cutting, grinding and cutting, water ring cutting and underwater pelletizing.
- the granulation method is carried out, and the water bath conditions of 25°C to 65°C are maintained during the production and processing; the prepared particles are dried in a blast drying oven to eliminate the impact of moisture on the properties of the particles, and at the same time, the particles are completely crystallized.
- the preparation method includes the following steps: preparing the polyhydroxyalkanoate composition according to the present invention at a temperature 10°C to 60°C higher than the melting temperature of the polyhydroxyalkanoate ester (No. Heating and melting at one temperature); extending more than 150% at a temperature (second temperature) between the glass transition temperature of the polyhydroxyalkanoate and the cold crystallization temperature; at the glass transition temperature of the polyhydroxyalkanoate Cooling and molding at a temperature between the melting temperature and the melting temperature (third temperature).
- the first temperature is not particularly limited, and is preferably above the melting temperature of the polyhydroxyalkanoate, and more preferably It is 10°C or higher of the melting temperature of the polyhydroxyalkanoate, and more preferably 20°C or higher of the melting temperature of the polyhydroxyalkanoate.
- the second temperature is too low or too high, the maximum stretch ratio of the polyhydroxyalkanoate molded body will be reduced and the transparency will be reduced. Therefore, preferably, when preparing the polyhydroxyalkanoate film molded body, cooling from the first temperature to the second temperature is a primary molding process, and secondary molding is performed by stretching at the second temperature.
- the second temperature is between the glass transition temperature and the cold crystallization temperature of the polyhydroxyalkanoate.
- the second temperature is between 20°C and the cold crystallization temperature of the polyhydroxyalkanoate; further preferably, it is between 30°C and the polyhydroxyalkanoate cold crystallization temperature. ester cold crystallization temperature.
- the second temperature may be, for example, 40°C, 45°C, 50°C, 53°C, 55°C, or 60°C.
- the crystallization is carried out at a third temperature, so that the polyhydroxyalkanoate molded body is better formed and has high stability and physical properties.
- the third temperature is between the glass transition temperature and the melting temperature of the polyhydroxyalkanoate.
- the third temperature may be, for example, 40°C, 45°C, 50°C, 55°C, or 60°C.
- the transparency of the polyhydroxyalkanoate shaped bodies prepared from the polyhydroxyalkanoate composition according to the invention is greatly improved.
- the light transmittance of the molded article obtained by the present invention is 80% or more and the haze is 50% or less.
- a fully biodegradable resin film product with a light transmittance of 90% or more and a haze of 40% or less and a total light transmittance of 90% or more and a haze of 30% or less was obtained.
- the nucleating agent for polyhydroxyalkanoate provided by the present invention has high nucleation efficiency, and can improve the shortcomings of polyhydroxyalkanoate in the process of preparing various molded bodies by thermoplastic processing, such as slow crystallization speed and low processing efficiency.
- the molded body provided by the present invention is subjected to secondary processing and molding at a second temperature lower than the melting temperature, and still maintains good transparency after the secondary processing and molding.
- the raw materials, reagents, methods, etc. used in the examples are all conventional raw materials, reagents, and methods in this field.
- Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBH), product number: BP330, Beijing Blue Crystal Microbial Technology Co., Ltd., the content of 3HB (3-hydroxybutyrate unit) is 94%, The weight average molecular weight is about 600,000-800,000.
- Poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBH), product number: BP350, Beijing Blue Crystal Microbial Technology Co., Ltd., the content of 3HB (3-hydroxybutyrate unit) is 89%, The weight average molecular weight is about 600,000-800,000.
- Poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV), Beijing Blue Crystal Microbial Technology Co., Ltd., has a weight average molecular weight of about 600,000-800,000.
- Poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (P34HB), Beijing Blue Crystal Microbial Technology Co., Ltd., weight average molecular weight is about 600,000-800,000.
- Preparation of particle moldings Use the compositions provided in Examples 1-15 and Comparative Examples 1-4 in Tables 1 to 3 respectively, and extrusion and granulate them with a twin-screw extruder.
- Step 1 Mixing: Place polyhydroxyalkanoate powder and nucleating agent in a high-speed mixer, mix at room temperature, mixing speed is 200r/min, mixing time is 5min; after mixing, mix Place it in the lower hopper of the twin-screw extruder (Nanjing Mianya Machinery JSH-65);
- Step 2 Extrusion: Set the conditions of the extrusion granulation equipment. The host speed is 50-500r/min. The feeding amount or production capacity is adjusted according to the actual production status; when the melt temperature is about 165°C (first temperature) Under the conditions, extrusion is carried out;
- Step 3 Granulation and cooling: Granulation is carried out by stretching and cutting in a water bath.
- the water bath temperature (granulation temperature) of each embodiment is shown in the table.
- Comparative Examples 5-7 the molded bodies of Comparative Examples 1-3 were respectively used for secondary processing to prepare films, and for Comparative Example 8, Example 7 was used for secondary processing to prepare films.
- the specific steps are: use a molding machine (produced by Jiangsu Tianyuan Company) to mold the particle molded bodies of the Examples and Comparative Examples. Molding is carried out at one temperature (melt temperature) to prepare a molded product with a thickness of 200 ⁇ m, and then placed in water at a second temperature (extension temperature) by holding both ends of the molded film to extend at a certain rate, and finally placed at a third temperature (heating temperature) in an oven to prepare a film sample.
- the specific process parameters are shown in Table 4.
- the preparation method of this film is the same as the core process of biaxially oriented film, so it can be compared to the biaxially oriented process.
- resins with crystallization enthalpy below 12.5J/g can be selected, and resins below 7.5J/g can be selected, and further options can be selected. Resin at 3.5J/g and below. Taking into account improving processing efficiency, for cold crystallization half-peak width, resins below 15°C can be selected, resins below 10°C can be selected, and resins below 8°C can be selected.
- ⁇ Can be processed continuously and stably, and the granulation is stable
- ⁇ Basically stable during thermoplastic processing, and the pelletizing state is average.
- the extruder is unstable during extrusion and cannot be continuously pelletized.
- Crystallinity (%) 100% ⁇ melting enthalpy/100% crystallization melting enthalpy;
- the 100% crystalline melting enthalpy is the theoretical enthalpy of 100% crystalline material.
- the crystallinity of the particle molded body of this example is greater and the half-peak width data of the secondary heating cold crystallization is smaller, indicating that it is more conducive to processing and molding; that is, the nucleating agent provided by the invention is used
- the thermoplastic processing difficulty of the obtained particle molded body is relatively low, and it can be processed continuously and stably.
- fatty acid ester nucleating agents as in Examples 1 to 4; add different types of fatty acid esters, as in Examples 5 to 6; use a single PHA, such as BP350 in Examples 1 to 6, and BP350 in Example 13. BP330; or mixed PHA, as in Examples 7 to 12, 14 to 15; using a single fatty acid ester, as in Examples 1 to 6; or mixed fatty acid esters, as in Examples 7 to 15, to obtain the overall particle molded body
- the surface has high crystallinity and can be processed continuously and stably.
- Example 13 Compared with the surface without adding nucleating agent, Proportion 1, and Comparative Examples 2, 3, and 4 in which existing nucleating agents such as calcium eicosate, boron nitride, and behenamide were added respectively.
- the overall nucleating effect of the fatty acid ester nucleating agent used in the present invention is better. It can be found that the crystallinity in Example 13 is the highest, and the half-peak width of the secondary heating cold crystallization cannot be measured. This may be related to the material itself.
- the raw material of Example 13 only contains PHBH-BP330, which itself is easy to crystallize, but its The crystallization enthalpy is large, which shows that the molded body has poor processability at the second temperature, which is not conducive to secondary molding.
- a particle molding with a crystallization enthalpy below 12.5 J/g is used; further, a particle molding with a crystallization enthalpy below 7.5 J/g is used, and further, a particle molding with a crystallization enthalpy below 3.5 J/g is used.
- a cold crystallized particle molded body with a half-peak width of 15°C or less can be used.
- a particle molded body having a cold crystallization half-peak width of 10° C. or less can be used.
- a cold crystallized particle molded product having a half-peak width of 8°C or less can be used.
- the present invention further selects the particle moldings in Examples 1, 2, 4, 6, and 11 to further prepare film moldings, and in order to expand the scope of application, the particle molding in Example 13 is selected.
- Example 7 is also selected as Comparative Example 8 without stretching
- Comparative Examples 1, 2, and 3 are respectively selected as Comparative Examples 5, 6, and 7.
- the specific parameters of the film moldings are shown in Table 4.
- thermoplastic processing difficulty of the molded film prepared by using the composition of the nucleating agent and polyhydroxyalkanoate of the present invention is relatively low, can be continuously and stably processed into the film, and the quality of the molded body is particularly transparent. Sex is better. That is, compared with existing nucleating agents, the fatty acid ester can obtain a molded body with high light transmittance, low haze, and good transparency.
- the light transmittance of the molded body obtained by the present invention is more than 80%, and the haze is less than 50%. In particular, the total light transmittance is more than 90%, the haze is less than 40%, and the total light transmittance is 90%. Above, fully biodegradable resin film products with a haze of less than 30%.
- Comparative Example 8 uses the raw materials of Example 7 to prepare a film at an elongation of 100%, that is, without stretching.
- the transparency of the film is significantly lower than that of Examples 16-23, and the haze is higher than that of Examples 16-23; in addition Examples 16-18 adopt different elongations.
- a temperature (second temperature) between the glass transition temperature and the cold crystallization temperature of the polyhydroxyalkanoate. elongation, and the higher the elongation, the greater the transparency of the prepared shaped body.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Biological Depolymerization Polymers (AREA)
Abstract
一种含酯类成核剂的聚羟基烷酸酯组合物、聚羟基烷酸酯成型体及其制备方法。所述聚羟基烷酸酯组合物包括聚羟基烷酸酯和成核剂,所述成核剂为酯类化合物,包括脂肪酸酯,尤其是碳原子数为大于5的脂肪酸酯中的一种或多种。聚羟基烷酸酯组合物中的成核剂成核效率高,可改善聚羟基烷酸酯在热塑加工制备各类成型体的过程中存在的结晶速度慢、加工效率低等缺点。所得聚羟基烷酸酯成型体具有透明度高、雾度低的优点。
Description
本发明涉及聚羟基烷酸酯材料技术领域,尤其是涉及一种含酯类成核剂的聚羟基烷酸酯组合物、聚羟基烷酸酯成型体及其制备方法。
聚羟基烷酸酯(PHAs或称PHA)是很多微生物合成的一种细胞内聚羟基脂肪酸酯,是一种天然的高分子生物材料。聚羟基烷酸酯的大多数单体是链长3~14个碳原子的3-羟基脂肪酸,其侧链是高度可变的饱和或不饱和、直链或支链、脂肪族或芳香族的基团,组成结构的多样性带来性能的多样化,使其在应用中具有明显的优势。同时,聚羟基烷酸酯是一种生物基来源且在海洋环境中可生物降解的聚合物,能够解决废弃塑料引起的环境问题,且具有优异的生物相容性和机械性能,因此可以被加工成各类的成型体,如薄膜、吸管、餐具等。
单纯的聚羟基烷酸酯在热塑加工制备各类成型体的过程中,存在结晶速率慢、结晶度低、加工效率低等缺点。现有技术往往通过添加成核剂等助剂的方法来提高PHAs的结晶速率。
现有技术中成核剂通常以无机物或金属盐为主,其虽能够一定程度提高传统聚羟基烷酸酯制备成型体的结晶速度及结晶度,但改善程度有限;更为重要的是,会导致成型体带有颜色,降低其透明度,影响其应用。
有鉴于此,特提出本发明。
发明内容
本发明的目的之一在于提供一种含酯类成核剂的聚羟基烷酸酯组合物。
本发明的目的之二在于提供一种聚羟基烷酸酯成型体,由上述聚羟基烷酸酯组合物制备得到。
本发明的目的之三在于提供一种制备上述聚羟基烷酸酯成型体的方法。
为了实现本发明的上述目的,特采用以下技术方案:
第一方面,本发明提供了一种聚羟基烷酸酯组合物,包括:
聚羟基烷酸酯,以及
成核剂,其中所述成核剂包括至少一种酯类化合物。
以下将详细说明聚羟基烷酸酯组合物中包含的示例性组分。
聚羟基烷酸酯
所述聚羟基烷酸酯可以为单独一种聚合物,也可以为两种以上聚合物的组合。其中每种聚合物的聚合单体可以为一种或多种(即聚合物中结构单元为一种或多种)。
具体而言,任一种聚合物含有以下通式(1)表示的结构单元:
其中,R1为CpH2p+1所示的烷基,p为1~15的整数,优选为1~10的整数,更优选为1~8的整数;作为R1,可列举例如:甲基、乙基、丙基、正丁基、异丁基、叔丁基、戊基、己基等直链或支链状的烷基;
n为1,2或3。
当n=1时,通式(1)表示3-羟基烷酸酯结构单元;当n=2时,通式(1)表示4-羟基烷酸酯结构单元;当n=3时,通式(1)表示5-羟基烷酸酯结构单元。其中,3-羟基烷酸酯结构单元和4-羟基烷酸酯结构单元较为常见,如3-羟基丁酸酯结构单元(以下有时称为3HB)、4-羟基丁酸酯结构单元(以下有时称为4HB)。
优选地,所述聚羟基烷酸酯包括至少一种聚(3-羟基烷酸酯)。
进一步地,所述聚(3-羟基烷酸酯)为仅包含3-羟基丁酸酯结构单元的聚(3-羟基丁酸酯)均聚物,或者为包含3-羟基丁酸酯结构单元和其他羟基烷酸酯结构单元的聚(3-羟基丁酸酯)共聚物。
进一步的,所述其他羟基烷酸酯结构单元包括:3-羟基丙酸酯、3-羟基戊酸酯、3-羟基己酸酯、3-羟基庚酸酯、3-羟基辛酸酯、3-羟基壬酸酯、3-羟基癸酸酯、3-羟基十一烷酸酯或4-羟基丁酸酯中的一种或多种;优选为3-羟基己酸酯。
简言之,作为聚(3-羟基烷酸酯)的具体例,可列举例如:聚(3-羟基丁酸酯)、聚(3-羟基丁酸酯-共-3-羟基丙酸酯)、聚(3-羟基丁酸酯-共-3-羟基戊酸酯)(简称:P3HB3HV,下称PHBV)、聚(3-羟基丁酸酯-共-3-羟基戊酸酯-共-3-羟基己酸酯)(下称P3HB3HV3HH)、聚(3-羟基丁酸酯-共-3-羟基己酸酯)(简称:P3HB3HH,下称PHBH)、聚(3-羟基丁酸酯-共-3-羟基庚酸酯)、聚(3-羟基丁酸酯-共-3-羟基辛酸酯)(下称PHBO)、聚(3-羟基丁酸酯-共-3-羟基壬酸酯)、聚(3-羟基丁酸酯-共-3-羟基癸酸酯)、聚(3-羟基丁酸酯-共-3-羟基十一烷酸酯)、聚(3-羟基丁酸酯-共-4-羟基丁酸酯)(简称:P3HB4HB,下称P34HB)等。特别
是从加工性及机械特性等观点考虑,优选聚(3-羟基丁酸酯-共-3-羟基己酸酯)。
对所述聚羟基烷酸酯的制造方法没有特别限定,可以是利用化学合成的制造方法,可以是利用微生物的制造方法。本发明所述聚羟基烷酸酯特别优选由微生物产生的聚羟基烷酸酯,在由微生物产生的聚羟基烷酸酯中,3-羟基烷酸酯结构单元全部以(R)3-羟基烷酸酯结构单元的形式含有。
在一些实施方式中,3-羟基丁酸酯结构单元和其他羟基烷酸酯结构单元的共聚物中,所述3-羟基丁酸酯结构单元与其他羟基烷酸酯结构单元的平均含有比率为50/50~99/1(摩尔%/摩尔%);优选为80/20~94/6(摩尔%/摩尔%);在聚羟基烷酸酯原料为两种以上聚羟基烷酸酯的混合物的情况下,平均含有比率是指混合物整体中所含的各单体的摩尔比。
在一些实施方式中,所述聚羟基烷酸酯的重均分子量为10万~100万;优选为20万~90万;进一步优选为30万~80万。重均分子量小于10万时,存在得到的聚羟基烷酸酯成型体的机械特性变低的倾向。另一方面,重均分子量超过100万时,存在熔融加工时对机械的负荷变高、生产性变低的倾向。
成核剂
本发明所述成核剂包括至少一种酯类化合物。
酯类化合物即分子内具有酯键的小分子化合物,即结构中含有-C(=O)O-基团的小分子化合物。
优选地,所述酯类化合物为脂肪酸酯类化合物,即R-COO-R'中,R为C5-C30的烷基(即合成R-COO-R'的R-COOH为脂肪酸),R'为C1-C16的烷基。
进一步的,所述成核剂为至少一种碳原子数大于5的脂肪酸酯;优选地,所述成核剂为至少一种碳原子数大于12的脂肪酸酯;更优选地,所述成核剂为至少一种碳原子数大于18的脂肪酸酯。对于碳原子数的上限没有特别限制,但是例如可以为45个以下,40个以下,或35个以下。
本发明研究发现,酯类化合物作为成核剂,包括脂肪酸酯类化合物,例如碳原子数大于5的脂肪酸酯作为制备聚羟基烷酸酯成型体中的成核剂,可显著提高聚羟基烷酸酯制备成型体时的结晶速度和结晶度,具有成核效率高、加工方式更加简便的优点,同时还能够使所制得的聚羟基烷酸酯成型体具有透明度高的优点,因而具有更广泛的应用场景。
从饱和度看,所述成核剂优选为饱和脂肪酸酯。
优选地,所述成核剂为选自十二酸丁酯(或称十二烷酸丁酯、月桂酸丁酯)、十五酸乙酯(或称十五烷酸乙酯)、十六酸甲酯(或称十六烷酸甲酯、棕榈酸甲酯)、十六酸乙酯
(或称十六烷酸乙酯、棕榈酸乙酯)、2-乙基己基十六酸酯(或称棕榈酸2-乙基己酯、棕榈酸辛酯)、十六酸十六酯(或称十六烷酸十六酯、棕榈酸棕榈酯、棕榈酸十六酯)、十八酸甲酯(或称硬脂酸甲酯)、十九酸甲酯、二十酸甲酯(或称花生酸甲酯)、二十酸乙酯(或称花生酸乙酯)、二十二酸甲酯(或称山嵛酸甲酯)、二十二酸乙酯(或称山嵛酸乙酯)、二十四酸甲酯(或称木蜡酸甲酯)、二十四酸乙酯(或称木蜡酸乙酯)、三十酸甲酯(或称蜂花酸甲酯、峰蜡酸甲酯)中的至少一种。
进一步优选地,所述成核剂为选自十六酸乙酯、2-乙基己基十六酸酯、十六酸十六酯、十九酸甲酯、二十酸甲酯、二十酸乙酯、二十二酸甲酯、二十二酸乙酯、二十四酸甲酯、二十四酸乙酯、三十酸甲酯中的至少一种。
在一些实施方式中,所述成核剂的添加量为所述聚羟基烷酸酯质量的0.01%-20%;优选为0.1%-5%;典型非限制性地,例如可以是0.1%、1%、2%、2.5%、3%、4%、5%。
研究表明,通过控制成核剂的添加比例在此优选范围内,可使得结晶效果更好,且制备的成型体可加工性能也更好。
本发明的聚羟基烷酸酯组合物可用本领域已知的常规技术和常规设备制备,可以直接在混料设备中混合得粉料,例如采用高速混料机中在室温下共混。
此外,在不抑制本发明效果的前提下,根据产品的生产需要,本发明的聚羟基烷酸酯组合物还可以含有添加剂等助剂。所述添加剂可包括增塑剂、交联剂、扩链剂、润滑剂等有机或无机材料。有机或无机材料可以单独使用,也可以两种以上组合使用。而且,还可以根据生产需要,调整添加剂的添加量,本发明对此没有特别限制。
第二方面,本发明还提供一种聚羟基烷酸酯成型体,由根据本发明的聚羟基烷酸酯组合物制备得到。
本发明所得聚羟基烷酸酯成型体具有透明度高、力学性能较好的优点,因而具有更广泛的应用场景。
本发明所述聚羟基烷酸酯成型体可包括多种形式,如薄膜、纤维、吸管、板材、粒料、纸塑、片材等。
第三方面,本发明还提供一种制备所述聚羟基烷酸酯成型体的方法,包括:用根据本发明的聚羟基烷酸酯组合物进行成型。
本发明的聚羟基烷酸酯成型体可以通过挤出成型、注塑成型、压延成型、流延成型、吹塑成型、双向拉伸成型等各种热加工成型方法制备而成,也可以通过溶液浇筑等非热加工成型方法制备而成。优选通过热加工成型方法制备。
本发明提供的聚羟基烷酸酯成型体的热加工成型制备方法包括以下步骤:将根据本发
明的聚羟基烷酸酯组合物在高于聚羟基烷酸酯的熔融温度的温度下加热熔融;在聚羟基烷酸酯的玻璃化转变温度与冷结晶温度之间的温度下进行延伸;在聚羟基烷酸酯的玻璃化转变温度与熔融温度之间的温度下冷却成型。
进一步地,当成型体为粒料时,可用造粒设备制作:可使用不同长径比的平行同向双螺杆挤出机、平行异向双螺杆挤出机、锥形双螺杆挤出机,以及单螺杆机等本领域常用挤出造粒设备;将组合物置于双螺杆挤出机的下料斗或失重秤中;挤出造粒设备的温度设定在50℃~180℃的范围内,主机转速为50-500r/min,喂料量或产能根据实际生产状态进行调整;后续可使风冷拉条切粒、水浴拉条切粒、磨面热切、水环切和水下切粒等切粒方式进行制粒,并在生产加工的过程中保持25℃~65℃的水浴条件;制备的粒子使用鼓风干燥箱,烘干,排除水分对粒子性能的影响,同时使粒子结晶完全。
进一步地,当成型体为薄膜时,所述制备方法包括以下步骤:将根据本发明的聚羟基烷酸酯组合物在比聚羟基烷酸酯的熔融温度高10℃~60℃的温度(第一温度)下加热熔融;在聚羟基烷酸酯的玻璃化转变温度与冷结晶温度之间的温度(第二温度)下进行150%以上的延伸;在聚羟基烷酸酯的玻璃化转变温度与熔融温度之间的温度(第三温度)下冷却成型。
聚羟基烷酸酯成型体在加工过程中,极易发生粘连,导致成型品的品质下降。因此,现有技术中,本领域技术人员所熟知的是可以通过延长加工时间,降低成型品的粘连,但是却大大降低了加工效率。
本发明人在研究中发现,考虑到混合的均匀性,在制备聚羟基烷酸酯成型体时,对第一温度没有特别限定,优选在所述聚羟基烷酸酯熔融温度以上,进一步优选为在所述聚羟基烷酸酯熔融温度的10℃以上,更进一步优选为在所述聚羟基烷酸酯熔融温度的20℃以上。此外,由于第二温度选择过低和过高,均会导致所述聚羟基烷酸酯成型体最大可延伸倍率下降,透明性降低。因此,优选地,在制备聚羟基烷酸酯薄膜成型体时,从第一温度降温到第二温度为一次成型过程,在第二温度下通过延伸进行二次成型。第二温度在聚羟基烷酸酯的玻璃化转变温度与冷结晶温度之间,优选第二温度在20℃至聚羟基烷酸酯冷结晶温度之间;进一步优选在30℃至聚羟基烷酸酯冷结晶温度之间。在研究过程中,发现在上述优选范围中,典型非限制性地,第二温度例如可以是40℃、45℃、50℃、53℃、55℃、60℃。最后,在第三温度下进行结晶定型,使所述聚羟基烷酸酯成型体更好成型、稳定物性高。优选第三温度在所述聚羟基烷酸酯的玻璃化转变温度与熔融温度之间,典型非限制性地,第三温度例如可以是40℃、45℃、50℃、55℃、60℃。
本研究发现,考虑到结晶焓越小,成型体在第二温度(延伸成型)下的加工成型性越
好,更利于二次成型,即第二温度下的延伸率可以越高。考虑到在第二温度(延伸成型)下易加工成型,对于结晶焓,当在12.5J/g以下时易加工,进一步在7.5J/g以下,更进一步在3.5J/g以下,更容易加工。考虑到二次升温冷结晶半峰宽数据越小,在加工过程中,成型体越易结晶***,更利于加工成型。考虑到提高加工效率,对于冷结晶半峰宽,当在15℃以下时容易提高加工效率,进一步选择在10℃以下,更进一步选择在8℃以下,更容易提高加工效率。
由根据本发明的聚羟基烷酸酯组合物制备的所述聚羟基烷酸酯成型体的透明度被极大提高。在本领域中,透光率越大、雾度越小,薄膜样品的透明性越好。本发明得到的成型体的透光率在80%以上、雾度在50%以下。尤其是实施例中进一步得到了透光率为90%以上、雾度为40%以下以及全光线透光率为90%以上、雾度为30%以下的可全生物降解的树脂薄膜制品。
1、本发明提供的用于聚羟基烷酸酯的成核剂成核效率高,可改善聚羟基烷酸酯在热塑加工制备各类成型体的过程中存在的结晶速度慢、加工效率低等缺点。
2、相比于现有其他成核剂,使用本发明提供的成核剂制备的各类聚羟基烷酸酯成型体的透明度较高,不会影响各类成型体的颜色。
3、本发明提供的成型体在低于熔融温度的第二温度下进行二次加工成型,且二次加工成型后仍然保持良好的透明度。
在上文中已经详细地描述了本发明,但是上述实施方式本质上仅是例示性,且并不欲限制本发明。此外,本文并不受前述现有技术或发明内容或以下实施例中所描述的任何理论的限制。
在本文中所披露的范围的端点和任何值都不限于该精确的范围或值,这些范围或值应当理解为包含接近这些范围或值的值。对于数值范围来说,各个范围的端点值之间、各个范围的端点值和单独的点值之间,以及单独的点值之间可以彼此组合而得到一个或多个新的数值范围,这些数值范围应被视为在本文中具体公开。
下面结合实施例对本发明作进一步的说明,需要说明的是,提供以下实施例仅出于说明目的并不构成对本发明要求保护范围的限制。
除特殊说明外,在实施例中所采用的原料、试剂、方法等均为本领域常规的原料、试剂、方法。
以下各实施例、对比例中用到的所有原料除特殊说明外,均为市售购买。
聚(3-羟基丁酸酯-共-3-羟基己酸酯)(PHBH),产品编号:BP330,北京蓝晶微生物科技有限公司,3HB(3-羟基丁酸酯单元)的含量94%,重均分子量约60-80万。
聚(3-羟基丁酸酯-共-3-羟基己酸酯)(PHBH),产品编号:BP350,北京蓝晶微生物科技有限公司,3HB(3-羟基丁酸酯单元)的含量89%,重均分子量约60-80万。
聚(3-羟基丁酸酯-共-3-羟基戊酸酯)(PHBV),北京蓝晶微生物科技有限公司,重均分子量约60-80万。
聚(3-羟基丁酸酯-共-4-羟基丁酸酯)(P34HB),北京蓝晶微生物科技有限公司,重均分子量约60-80万。
聚(3-羟基丁酸酯-共-3-羟基辛酸酯)(PHBO),北京蓝晶微生物科技有限公司,重均分子量约60-80万。
聚(3-羟基丁酸酯-共-3-羟基戊酸酯-共-3-羟基己酸酯(P3HB3HV3HH),北京蓝晶微生物科技有限公司,重均分子量约60-80万。
实施例1~15和对比例1~4制备粒子成型体
制作粒子成型体:分别采用表1-表3中实施例1-15及对比例1-4提供的组合物,用双螺杆挤出机挤出造粒。
具体步骤为:
步骤1、混料:将聚羟基烷酸酯粉末与成核剂置于高速混料机中,在室温下混料,混料转速200r/min,混料时间5min;混料后,将混料置于双螺杆挤出机(南京棉亚机械JSH-65)的下料斗中;
步骤2、挤出:设定挤出造粒设备的条件,主机转速为50-500r/min,喂料量或产能根据实际生产状态进行调整;在熔体温度165℃左右(第一温度)的条件下,进行挤出;
步骤3、造粒冷却:采用水浴拉条切粒的方式进行造粒,各实施例的水浴温度(造粒温度)见表中所示。
实施例16~23和对比例5~8制备薄膜成型体
实施例16-23优选实施例1-15中部分实施例的成型体进行二次加工制备薄膜。当然这里需要注意的是,采用实施例1-15组合物直接制备薄膜也是可以的,应当在本发明保护范围内。
对比例5-7分别使用对比例1-3的成型体进行二次加工制备薄膜,对比例8使用实施例7进行二次加工制备薄膜。
具体步骤为:使用模压机(江苏天源公司产),将实施例和对比例的粒子成型体于第
一温度(熔体温度)下进行模压、制备成厚度为200μm的模压品,继而放入第二温度(延伸温度)的水中手持模压膜的两端进行一定倍率的延伸,最后放于第三温度(加热温度)的烘箱中进行加热,制得薄膜样品。具体工艺参数如表4所示。
本薄膜的制备方法与双向拉伸薄膜的核心工艺相同,因此,可类比到双向拉伸工艺。
为达到延伸率>150%,考虑到在第二温度下易加工成型,对于结晶焓,可选在12.5J/g以下的树脂,进一步可选在7.5J/g以下的树脂,更进一步可选在3.5J/g及以下的树脂。考虑到提高加工效率,对于冷结晶半峰宽,可选在15℃以下的树脂,进一步可选在10℃以下的树脂,更进一步可选在8℃以下的树脂。
<聚羟基烷酸酯成型体的性能评价>
热塑加工难度:
○:可连续稳定加工,切粒稳定;
△:热塑加工时基本稳定,切粒状态一般。
×:挤出机挤出时不稳定,无法连续切粒。
结晶度:
使用差示扫描量热计(TA Instrument公司制DSC25型),计量聚羟基烷酸酯成型体2-10mg,以10℃/分的升温速度从-50℃一次升温至180℃时得到DSC曲线。进一步得到聚羟基烷酸酯组合物DSC曲线中的玻璃化转变温度、熔融温度、熔融峰面积、冷结晶峰面积等数据。
结晶度(%)=100%×熔融焓/100%结晶熔融焓;
其中,100%结晶熔融焓为100%结晶材料的理论热焓。结晶度越大,说明成型体的结晶性越高,更利于后续加工成型。
降温结晶焓:
使用差示扫描量热计(TA Instrument公司制DSC25型),计量聚羟基烷酸酯成型体2-10mg,以10℃/min的升温速度从-50℃一次升温至180℃,以10℃/min的降温速度从180℃降温至-50℃,得到降温曲线,从降温曲线上得到结晶焓。
结晶焓越小,成型体在第二温度下的加工成型性越好,更利于二次成型,即二次温度下的延伸率可以越高。
二次升温的冷结晶半峰宽:
使用差示扫描量热计(TA Instrument公司制DSC25型),计量聚羟基烷酸酯成型体2-10mg,以10℃/min的升温速度从-50℃一次升温至180℃,在180℃保温3min,以10℃/min
的降温速度从180℃降温至-50℃,以10℃/min的升温速度从-50℃二次升温至180℃得到二次升温的DSC曲线。在二次升温的DSC曲线具有冷结晶峰的情况下,从二次升温曲线上得到冷结晶半峰宽。
二次升温冷结晶半峰宽数据越小,在加工过程中,成型体越易结晶***,更利于加工成型。
透光率和雾度:
将5cm×5cm的样品,使用日本SUGA雾度计HZ-V3,以D65为光源,测定雾度和透光率。
透光率越大、雾度越小,薄膜样品的透明性越好。
结果提供在以下表1至表4中。
表1
表2
注:—表示无测试结果。
注:—表示无测试结果。
表3
由以上结果可知,相较于对比例,本实施例粒子成型体的结晶度更大、二次升温冷结晶半峰宽数据较小,说明更利于加工成型;即采用本发明提供的成核剂制得的粒子成型体的热塑加工难度相对更低,可连续稳定加工。
添加不同含量的脂肪酸酯成核剂,如实施例1~4;添加不同种类的脂肪酸酯,如实施例5~6;采用单一PHA,如实施例1~6采用BP350、实施例13采用BP330;或混料PHA,如实施例7~12、14~15;采用单一脂肪酸酯,如实施例1~6;或混合脂肪酸酯,如实施例7~15,得到的粒子成型体总体上结晶度高,可连续稳定加工,相比于未添加成核剂的对
比例1,以及分别添加了二十酸钙、氮化硼、二十二酰胺等现有成核剂的对比例2、3、4,本发明采用的脂肪酸酯类成核剂总体上成核效果更好。可以发现,实施例13中的结晶度最高,且测不出二次升温冷结晶半峰宽,这可能和材料本身有关,实施例13原料中仅含有PHBH-BP330,其本身容易结晶,但是其结晶焓较大,可见其成型体在第二温度下的加工成型性差,不利于二次成型。
考虑到在第二温度(延伸成型)下易加工成型,因此,再进一步制备薄膜成型体时,采用结晶焓在12.5J/g以下的粒子成型体;进一步采用结晶焓在7.5J/g以下的粒子成型体,更进一步采用结晶焓在3.5J/g以下的粒子成型体。
考虑到二次升温冷结晶半峰宽数据越小,在加工过程中,成型体越易结晶***,更利于加工成型。因此,再进一步制备薄膜成型体时,为了进一步提高加工效率,可采用冷结晶半峰宽在15℃以下的粒子成型体。可进一步采用冷结晶半峰宽在10℃以下的粒子成型体。可更进一步采用冷结晶半峰宽在8℃以下的粒子成型体。
基于此,本发明进一步选用实施例1、2、4、6、11中的粒子成型体进一步制备薄膜成型体,为了拓展适用范围选取了实施例13中的粒子成型体。为进一步探究延伸倍率的关系,还选择实施例7作为未经过延伸的对比例8,以及对比例1、2、3分别作为对比例5、6、7。具体的薄膜成型体的参数如下表4。
表4
由以上结果可知,采用本发明的成核剂与聚羟基烷酸酯的组合物制得的成型体薄膜的热塑加工难度相对更低,可连续稳定加工成膜,且成型体品质特别是透明性更好。即脂肪酸酯相比于现有的成核剂,获得的成型体透光率高、雾度低,透明性好。本发明得到的成型体的透光率在80%以上,雾度在50%以下,尤其得到了全光线透光率为90%以上,雾度为40%以下以及全光线透光率为90%以上,雾度为30%以下的可全生物降解的树脂薄膜制品。
采用不同工艺参数,如实施例16~18,不同原料,如实施例19~23制得的成型体薄膜性能有差异,但总体透明度好。此外,对比例8采用实施例7的原料在延伸率100%也就是不拉伸的情况下制备薄膜,薄膜透明度明显低于实施例16-23,且雾度高于实施例16-23;此外实施例16-18采用不同的延伸率,可见,当成型体为薄膜时,优选在聚羟基烷酸酯的玻璃化转变温度与冷结晶温度之间的温度(第二温度)下进行150%以上的延伸,且延伸率越高,制备的成形体的透明度增大。
以上各实施例仅用以举例说明本发明的技术方案,而非对其限制。尽管参照前述各实施例对本发明进行了详细的说明,本领域的普通技术人员应当理解:在没有脱离本发明所限定的精神和实质的范围内,可以对前述各实施例所记载的技术方案进行修改,或者对其中部分或者全部技术特征进行等同替换;而这些修改或者替换仍然在本发明所限定的范围内。
Claims (10)
- 一种含酯类成核剂的聚羟基烷酸酯组合物,其特征在于,包括:聚羟基烷酸酯,以及成核剂,其中所述成核剂包括至少一种酯类化合物。
- 根据权利要求1所述的聚羟基烷酸酯组合物,其特征在于,所述成核剂的添加量为所述聚羟基烷酸酯质量的0.1%-5%。
- 根据权利要求2所述的聚羟基烷酸酯组合物,其特征在于,所述成核剂为至少一种碳原子数大于5的饱和脂肪酸酯。
- 根据权利要求3所述的聚羟基烷酸酯组合物,其特征在于,所述成核剂为选自十二酸丁酯、十五酸乙酯、十六酸甲酯、十六酸乙酯、2-乙基己基十六酸酯、十六酸十六酯、十八酸甲酯、十九酸甲酯、二十酸甲酯、二十酸乙酯、二十二酸甲酯、二十二酸乙酯、二十四酸甲酯、二十四酸乙酯、三十酸甲酯中的至少一种。
- 根据权利要求1-4任一项所述的聚羟基烷酸酯组合物,其特征在于,所述聚羟基烷酸酯含有以下通式(1)表示的结构单元:
其中,R1为CpH2p+1所示的烷基,p为1~15的整数;n为1,2或3。 - 根据权利要求5所述的聚羟基烷酸酯组合物,其特征在于,所述聚羟基烷酸酯为选自聚(3-羟基丁酸酯)、聚(3-羟基丁酸酯-共-3-羟基丙酸酯)、聚(3-羟基丁酸酯-共-3-羟基戊酸酯)、聚(3-羟基丁酸酯-共-3-羟基戊酸酯-共-3-羟基己酸酯)、聚(3-羟基丁酸酯-共-3-羟基己酸酯)、聚(3-羟基丁酸酯-共-3-羟基庚酸酯)、聚(3-羟基丁酸酯-共-3-羟基辛酸酯)、聚(3-羟基丁酸酯-共-3-羟基壬酸酯)、聚(3-羟基丁酸酯-共-3-羟基癸酸酯)、聚(3-羟基丁酸酯-共-3-羟基十一烷酸酯)、聚(3-羟基丁酸酯-共-4-羟基丁酸酯)中的至少一种。
- 一种聚羟基烷酸酯成型体,其特征在于,由权利要求1-6任一项所述的聚羟基烷酸酯组合物制备得到。
- 一种制备聚羟基烷酸酯成型体的方法,其特征在于,包括以下步骤:将权利要求1-6任一项所述的聚羟基烷酸酯组合物在高于聚羟基烷酸酯的熔融温度的温 度下加热熔融;在聚羟基烷酸酯的玻璃化转变温度与冷结晶温度之间的温度下进行延伸;在聚羟基烷酸酯的玻璃化转变温度与熔融温度之间的温度下冷却成型。
- 根据权利要求8所述的方法,其特征在于,在比聚羟基烷酸酯的熔融温度高10℃~60℃的温度下加热熔融;在聚羟基烷酸酯的玻璃化转变温度与冷结晶温度之间的温度下进行150%以上的延伸。
- 根据权利要求9所述的方法,其特征在于,所述聚羟基烷酸酯成型体的结晶焓在12.5J/g以下,和/或,冷结晶半峰宽在15℃以下。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211156109.5A CN115232455B (zh) | 2022-09-22 | 2022-09-22 | 含酯类成核剂的聚羟基烷酸酯组合物、聚羟基烷酸酯成型体及其制备方法 |
CN202211156109.5 | 2022-09-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024060636A1 true WO2024060636A1 (zh) | 2024-03-28 |
Family
ID=83667293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2023/092674 WO2024060636A1 (zh) | 2022-09-22 | 2023-05-08 | 含酯类成核剂的聚羟基烷酸酯组合物、聚羟基烷酸酯成型体及其制备方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN115232455B (zh) |
WO (1) | WO2024060636A1 (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115232455B (zh) * | 2022-09-22 | 2023-01-17 | 北京蓝晶微生物科技有限公司 | 含酯类成核剂的聚羟基烷酸酯组合物、聚羟基烷酸酯成型体及其制备方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007262422A (ja) * | 2004-05-11 | 2007-10-11 | Kao Corp | 生分解性樹脂組成物 |
CN101538750A (zh) * | 2008-03-18 | 2009-09-23 | 天津国韵生物材料有限公司 | 聚羟基脂肪酸酯纤维及其制备方法 |
WO2021206154A1 (ja) * | 2020-04-09 | 2021-10-14 | 株式会社カネカ | 脂肪族ポリエステル繊維の製造方法、脂肪族ポリエステル繊維及びマルチフィラメント |
CN114989586A (zh) * | 2022-06-02 | 2022-09-02 | 北京蓝晶微生物科技有限公司 | 含醇类成核剂的聚羟基烷酸酯组合物、聚羟基烷酸酯成型体及其制备方法 |
CN115232455A (zh) * | 2022-09-22 | 2022-10-25 | 北京蓝晶微生物科技有限公司 | 含酯类成核剂的聚羟基烷酸酯组合物、聚羟基烷酸酯成型体及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6417294B1 (en) * | 1995-12-21 | 2002-07-09 | Mitsui Chemicals, Inc. | Films and molded articles formed from aliphatic polyester compositions containing nucleating agents |
US7354973B2 (en) * | 2003-12-12 | 2008-04-08 | E.I. Du Pont De Nemours And Company | Toughened poly(lactic acid) compositions |
US7301000B2 (en) * | 2004-09-15 | 2007-11-27 | The Procter & Gamble Company | Nucleating agents for polyhydroxyalkanoates |
WO2009048797A1 (en) * | 2007-10-10 | 2009-04-16 | E.I. Du Pont De Nemours And Company | Poly(hydroxyalkanoic acid) and thermoformed articles |
CN102020756B (zh) * | 2010-11-15 | 2013-01-16 | 北京大学 | Pet成核剂及其生产方法,和pet改性方法 |
CN115044180B (zh) * | 2022-08-12 | 2022-12-06 | 北京蓝晶微生物科技有限公司 | 包含结晶促进剂的聚羟基烷酸酯组合物和成型体 |
-
2022
- 2022-09-22 CN CN202211156109.5A patent/CN115232455B/zh active Active
-
2023
- 2023-05-08 WO PCT/CN2023/092674 patent/WO2024060636A1/zh unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007262422A (ja) * | 2004-05-11 | 2007-10-11 | Kao Corp | 生分解性樹脂組成物 |
CN101538750A (zh) * | 2008-03-18 | 2009-09-23 | 天津国韵生物材料有限公司 | 聚羟基脂肪酸酯纤维及其制备方法 |
WO2021206154A1 (ja) * | 2020-04-09 | 2021-10-14 | 株式会社カネカ | 脂肪族ポリエステル繊維の製造方法、脂肪族ポリエステル繊維及びマルチフィラメント |
CN114989586A (zh) * | 2022-06-02 | 2022-09-02 | 北京蓝晶微生物科技有限公司 | 含醇类成核剂的聚羟基烷酸酯组合物、聚羟基烷酸酯成型体及其制备方法 |
CN115232455A (zh) * | 2022-09-22 | 2022-10-25 | 北京蓝晶微生物科技有限公司 | 含酯类成核剂的聚羟基烷酸酯组合物、聚羟基烷酸酯成型体及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN115232455A (zh) | 2022-10-25 |
CN115232455B (zh) | 2023-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108795001B (zh) | 一种可生物降解聚合物组合物及其应用 | |
CN115232456B (zh) | 含羟基酸类成核剂的聚羟基烷酸酯组合物、聚羟基烷酸酯成型体及其制备方法 | |
WO2023221849A1 (zh) | 聚羟基烷酸酯的酸类成核剂及聚羟基烷酸酯成型体 | |
JP7082667B2 (ja) | ポリ乳酸複合材及びその使用 | |
WO2023231732A1 (zh) | 含醇类成核剂的聚羟基烷酸酯组合物、聚羟基烷酸酯成型体及其制备方法 | |
JP2005501927A (ja) | 核剤および可塑剤を用いたポリヒドロキシアルカノエートの加工 | |
WO2024007494A1 (zh) | 一种聚羟基烷酸酯成型体及其制备方法 | |
CN115386211B (zh) | 含多元酸的聚羟基烷酸酯组合物及聚羟基烷酸酯成型体 | |
WO2024045338A1 (zh) | 一种可降解材料的造粒加工方法及其制备的成型体 | |
WO2024060636A1 (zh) | 含酯类成核剂的聚羟基烷酸酯组合物、聚羟基烷酸酯成型体及其制备方法 | |
WO2023245997A1 (zh) | 可海洋降解的聚羟基烷酸酯组合物、成型体及其制备方法 | |
CN115044180B (zh) | 包含结晶促进剂的聚羟基烷酸酯组合物和成型体 | |
WO2024031897A1 (zh) | 聚羟基烷酸酯组合物及其成型体 | |
US6774158B2 (en) | Processing of polyhydroxyalkanoates using a nucleant and a plasticizer | |
JP4326832B2 (ja) | 生分解性ポリエステル系樹脂組成物の製造方法 | |
JPH01193354A (ja) | 樹脂組成物 | |
CN117209980B (zh) | 一种聚羟基脂肪酸酯组合物、聚羟基脂肪酸酯成型体及其制备方法 | |
CN113563700A (zh) | 一种含酰肼型成核剂的聚乳酸组合物及其制备方法 | |
JP4368078B2 (ja) | 液晶ポリエステル樹脂組成物 | |
CN115232451A (zh) | 一种可快速结晶的聚羟基烷酸酯材料或制品及其制备方法 | |
JP2024529147A (ja) | ポリヒドロキシアルカノエート成形体及びその製造方法 | |
JPS59204655A (ja) | ポリエチレンテレフタレ−ト樹脂組成物 | |
CN114410074A (zh) | 一种透明耐热pet材料及其制备方法与应用 | |
JPH02103257A (ja) | ポリエステル樹脂組成物 | |
JPH01170646A (ja) | ポリエステル樹脂組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23866933 Country of ref document: EP Kind code of ref document: A1 |